Concomitant chemoradiation treatment in the management of patients with extrahepatic biliary tract recurrence of gastric carcinoma

Su Shun Lo, Chew Wun Wu, Kwan Hwa Chi, Hsiuo Shan Tseng, King Han Shen, Mao-Chih Hsieh, Wing Yiu Lui

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

BACKGROUND. The aim of this study was to determine the role of concomitant chemoradiation in the alleviation of obstructive jaundice in patients with extrahepatic biliary tract metastases from gastric carcinoma. METHODS. Thirteen patients with good performance status who had obstructive jaundice resulting from extrahepatic biliary metastases after gastrectomy for gastric carcinoma were treated with palliative intent. Treatment consisted of insertion of a percutaneous transhepatic choledochal drainage (PTCD) catheter followed by external radiation up to a total dose of 40-60 grays in combination with chemotherapy (cisplatin 20 mg/m2/day, 5-fluorouracil 600 mg/m2/day, and leucovorin 90 mg/m2/day for 96 hours during the first and fifth weeks) on an outpatient basis. RESULTS. The concomitant chemoradiation produced a good palliative effect in all 13 patients. Hyperbilirubinemia continued to improve after treatment, patients' clay-colored stool resolved within an average of 4 weeks (range, 2-6 weeks), and bilirubin levels returned to normal. The PTCD catheter could be removed after treatment was completed (the seventh week); the mean duration of PTCD placement was 2 months. The entire treatment course was performed on an outpatient basis; hospital admission was necessary only for PTCD insertion and chemotherapy. Ten patients died of their disease, with an average survival of 14.4 months (range, 4-31 months) from the time of PTCD insertion. Three patients are still alive at 16, 21, and 8 months. Biliary tract patency was maintained until death. No serious treatment-related complications occurred, and no endoprothesis or intraluminal brachytherapy was needed in this study. CONCLUSIONS. Satisfactory palliation can be achieved by concomitant chemoradiation for patients with obstructive jaundice resulting from extrahepatic biliary metastases from gastric carcinoma, providing an alternative treatment choice for these patients. (C) 2000 American Cancer Society.

Original languageEnglish
Pages (from-to)29-34
Number of pages6
JournalCancer
Volume89
Issue number1
DOIs
Publication statusPublished - Jul 1 2000
Externally publishedYes

Fingerprint

Biliary Tract
Stomach
Carcinoma
Recurrence
Drainage
Obstructive Jaundice
Therapeutics
Neoplasm Metastasis
Outpatients
Catheters
Hyperbilirubinemia
Leucovorin
Brachytherapy
Gastrectomy
Combination Drug Therapy
Bilirubin
Fluorouracil
Cisplatin
Radiation
Drug Therapy

Keywords

  • Chemoradiation
  • Malignant biliary obstruction
  • Recurrent gastric carcinoma

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Concomitant chemoradiation treatment in the management of patients with extrahepatic biliary tract recurrence of gastric carcinoma. / Lo, Su Shun; Wu, Chew Wun; Chi, Kwan Hwa; Tseng, Hsiuo Shan; Shen, King Han; Hsieh, Mao-Chih; Lui, Wing Yiu.

In: Cancer, Vol. 89, No. 1, 01.07.2000, p. 29-34.

Research output: Contribution to journalArticle

Lo, Su Shun ; Wu, Chew Wun ; Chi, Kwan Hwa ; Tseng, Hsiuo Shan ; Shen, King Han ; Hsieh, Mao-Chih ; Lui, Wing Yiu. / Concomitant chemoradiation treatment in the management of patients with extrahepatic biliary tract recurrence of gastric carcinoma. In: Cancer. 2000 ; Vol. 89, No. 1. pp. 29-34.
@article{0a29b4071ad04d8eb88f8ad33d933208,
title = "Concomitant chemoradiation treatment in the management of patients with extrahepatic biliary tract recurrence of gastric carcinoma",
abstract = "BACKGROUND. The aim of this study was to determine the role of concomitant chemoradiation in the alleviation of obstructive jaundice in patients with extrahepatic biliary tract metastases from gastric carcinoma. METHODS. Thirteen patients with good performance status who had obstructive jaundice resulting from extrahepatic biliary metastases after gastrectomy for gastric carcinoma were treated with palliative intent. Treatment consisted of insertion of a percutaneous transhepatic choledochal drainage (PTCD) catheter followed by external radiation up to a total dose of 40-60 grays in combination with chemotherapy (cisplatin 20 mg/m2/day, 5-fluorouracil 600 mg/m2/day, and leucovorin 90 mg/m2/day for 96 hours during the first and fifth weeks) on an outpatient basis. RESULTS. The concomitant chemoradiation produced a good palliative effect in all 13 patients. Hyperbilirubinemia continued to improve after treatment, patients' clay-colored stool resolved within an average of 4 weeks (range, 2-6 weeks), and bilirubin levels returned to normal. The PTCD catheter could be removed after treatment was completed (the seventh week); the mean duration of PTCD placement was 2 months. The entire treatment course was performed on an outpatient basis; hospital admission was necessary only for PTCD insertion and chemotherapy. Ten patients died of their disease, with an average survival of 14.4 months (range, 4-31 months) from the time of PTCD insertion. Three patients are still alive at 16, 21, and 8 months. Biliary tract patency was maintained until death. No serious treatment-related complications occurred, and no endoprothesis or intraluminal brachytherapy was needed in this study. CONCLUSIONS. Satisfactory palliation can be achieved by concomitant chemoradiation for patients with obstructive jaundice resulting from extrahepatic biliary metastases from gastric carcinoma, providing an alternative treatment choice for these patients. (C) 2000 American Cancer Society.",
keywords = "Chemoradiation, Malignant biliary obstruction, Recurrent gastric carcinoma",
author = "Lo, {Su Shun} and Wu, {Chew Wun} and Chi, {Kwan Hwa} and Tseng, {Hsiuo Shan} and Shen, {King Han} and Mao-Chih Hsieh and Lui, {Wing Yiu}",
year = "2000",
month = "7",
day = "1",
doi = "10.1002/1097-0142(20000701)89:1<29::AID-CNCR5>3.0.CO;2-I",
language = "English",
volume = "89",
pages = "29--34",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Concomitant chemoradiation treatment in the management of patients with extrahepatic biliary tract recurrence of gastric carcinoma

AU - Lo, Su Shun

AU - Wu, Chew Wun

AU - Chi, Kwan Hwa

AU - Tseng, Hsiuo Shan

AU - Shen, King Han

AU - Hsieh, Mao-Chih

AU - Lui, Wing Yiu

PY - 2000/7/1

Y1 - 2000/7/1

N2 - BACKGROUND. The aim of this study was to determine the role of concomitant chemoradiation in the alleviation of obstructive jaundice in patients with extrahepatic biliary tract metastases from gastric carcinoma. METHODS. Thirteen patients with good performance status who had obstructive jaundice resulting from extrahepatic biliary metastases after gastrectomy for gastric carcinoma were treated with palliative intent. Treatment consisted of insertion of a percutaneous transhepatic choledochal drainage (PTCD) catheter followed by external radiation up to a total dose of 40-60 grays in combination with chemotherapy (cisplatin 20 mg/m2/day, 5-fluorouracil 600 mg/m2/day, and leucovorin 90 mg/m2/day for 96 hours during the first and fifth weeks) on an outpatient basis. RESULTS. The concomitant chemoradiation produced a good palliative effect in all 13 patients. Hyperbilirubinemia continued to improve after treatment, patients' clay-colored stool resolved within an average of 4 weeks (range, 2-6 weeks), and bilirubin levels returned to normal. The PTCD catheter could be removed after treatment was completed (the seventh week); the mean duration of PTCD placement was 2 months. The entire treatment course was performed on an outpatient basis; hospital admission was necessary only for PTCD insertion and chemotherapy. Ten patients died of their disease, with an average survival of 14.4 months (range, 4-31 months) from the time of PTCD insertion. Three patients are still alive at 16, 21, and 8 months. Biliary tract patency was maintained until death. No serious treatment-related complications occurred, and no endoprothesis or intraluminal brachytherapy was needed in this study. CONCLUSIONS. Satisfactory palliation can be achieved by concomitant chemoradiation for patients with obstructive jaundice resulting from extrahepatic biliary metastases from gastric carcinoma, providing an alternative treatment choice for these patients. (C) 2000 American Cancer Society.

AB - BACKGROUND. The aim of this study was to determine the role of concomitant chemoradiation in the alleviation of obstructive jaundice in patients with extrahepatic biliary tract metastases from gastric carcinoma. METHODS. Thirteen patients with good performance status who had obstructive jaundice resulting from extrahepatic biliary metastases after gastrectomy for gastric carcinoma were treated with palliative intent. Treatment consisted of insertion of a percutaneous transhepatic choledochal drainage (PTCD) catheter followed by external radiation up to a total dose of 40-60 grays in combination with chemotherapy (cisplatin 20 mg/m2/day, 5-fluorouracil 600 mg/m2/day, and leucovorin 90 mg/m2/day for 96 hours during the first and fifth weeks) on an outpatient basis. RESULTS. The concomitant chemoradiation produced a good palliative effect in all 13 patients. Hyperbilirubinemia continued to improve after treatment, patients' clay-colored stool resolved within an average of 4 weeks (range, 2-6 weeks), and bilirubin levels returned to normal. The PTCD catheter could be removed after treatment was completed (the seventh week); the mean duration of PTCD placement was 2 months. The entire treatment course was performed on an outpatient basis; hospital admission was necessary only for PTCD insertion and chemotherapy. Ten patients died of their disease, with an average survival of 14.4 months (range, 4-31 months) from the time of PTCD insertion. Three patients are still alive at 16, 21, and 8 months. Biliary tract patency was maintained until death. No serious treatment-related complications occurred, and no endoprothesis or intraluminal brachytherapy was needed in this study. CONCLUSIONS. Satisfactory palliation can be achieved by concomitant chemoradiation for patients with obstructive jaundice resulting from extrahepatic biliary metastases from gastric carcinoma, providing an alternative treatment choice for these patients. (C) 2000 American Cancer Society.

KW - Chemoradiation

KW - Malignant biliary obstruction

KW - Recurrent gastric carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0034234665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034234665&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(20000701)89:1<29::AID-CNCR5>3.0.CO;2-I

DO - 10.1002/1097-0142(20000701)89:1<29::AID-CNCR5>3.0.CO;2-I

M3 - Article

C2 - 10896997

AN - SCOPUS:0034234665

VL - 89

SP - 29

EP - 34

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 1

ER -